What is the normal anti‑Müllerian hormone (AMH) level for a woman of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Anti-Müllerian Hormone (AMH) Levels for Women of Reproductive Age

Normal AMH levels vary significantly by age, but generally range from approximately 1.0-4.0 ng/mL (7-28 pmol/L) for women in their reproductive years, with progressive decline after age 25 and accelerated decline after age 35-40.

Age-Specific Reference Ranges

The most clinically useful approach is to interpret AMH using age-specific percentiles rather than a single "normal" value, as AMH declines progressively throughout reproductive life 1, 2, 3.

Detailed Age-Specific Ranges (2.5th-97.5th percentiles):

Ages 20-25 years:

  • 0.87-9.89 ng/mL (approximately 6-70 pmol/L) 1
  • Median: ~3.62 µg/L 4

Ages 26-30 years:

  • 0.42-8.24 ng/mL (approximately 3-59 pmol/L) 1
  • Median: ~3.10 µg/L 4

Ages 31-35 years:

  • 0.34-7.46 ng/mL (approximately 2-53 pmol/L) 1
  • Median: ~2.27 µg/L 4

Ages 36-40 years:

  • 0.28-5.66 ng/mL (approximately 2-40 pmol/L) 1
  • Median: ~1.07 µg/L 4
  • Note: Significant decline begins after age 36 4

Ages 41-45 years:

  • 0.12-4.63 ng/mL (early 40s) declining to 0.01-2.65 ng/mL (mid-40s) 1
  • Median: ~0.45 µg/L (≥41 years) 4

Key Clinical Thresholds

Low AMH (Diminished Ovarian Reserve):

  • <0.7-1.1 ng/mL (<5-8 pmol/L) is generally considered low across multiple studies 5
  • Values <1.0 ng/mL associated with increased miscarriage risk 5
  • Severe diminished ovarian reserve: <0.7 ng/mL 5

High AMH (Possible PCOS):

  • >2.0-5.6 ng/mL (>14-40 pmol/L) depending on age and assay 5
  • AMH should not be used as a single diagnostic test for PCOS per international guidelines 6

Important Clinical Considerations

Assay Variability

Different AMH assays have varying sensitivities and reference ranges. Always interpret results in the context of the specific assay used and the laboratory's reference ranges 6. Newer ultrasensitive assays (detection limit 0.003 ng/mL) provide better discrimination in perimenopausal women 7.

Age-Related Decline Pattern

AMH follows a quadratic decline model: log(AMH) = 0.205 × age - 0.005 × age² - 0.047 3. The decline accelerates around age 36-40, marking the beginning of accelerated ovarian aging 1, 4.

Clinical Utility Limitations

  • AMH should NOT be used alone to diagnose PCOS - it requires clinical and ultrasound correlation 6
  • AMH reflects ovarian reserve but does not directly predict fertility in natural conception
  • In women <8 years post-menarche, AMH interpretation is unreliable due to high prevalence of multifollicular ovaries 6

Ethnic Considerations

Reference ranges may vary by ethnicity. The studies cited include Chinese 1, 4, Omani 2, and mixed populations 3, suggesting some population-specific variation exists.

Practical Application

For fertility counseling: Use age-specific percentiles rather than absolute cutoffs. A woman with AMH at the 10th percentile for her age has diminished reserve relative to peers and may experience faster decline 7.

For miscarriage risk assessment: AMH <1.0 ng/mL is associated with increased miscarriage risk (OR 1.35,95% CI 1.10-1.66), with higher risk when AMH <0.7 ng/mL (OR 1.63-1.91) 5.

For menopause prediction: Very low AMH (<0.1 ng/mL) suggests proximity to menopause, though sensitivity and specificity are limited for precise timing 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.